Pharmafile Logo

Creative Biogene

Creative Biogene is the leading global client service and solutions provider for scientific research, and is committed to the development, manufacture and purification of recombinant adenoviruses, adeno-associated virus (AAV) and lentivirus for gene delivery and gene knock down. With above 20 years of gene delivery tools development experience, Creative Biogene is specialized in providing gene delivery and gene knock down services that cover the full scope of biotechnology needs of early drug discovery and drug development.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Company Details

45-16 Ramsey Road Shirley, New York, NY 11967, United States
+1 631 624 4882

 Latest Content from PMHub 

AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH

Through sustained partnerships between advocacy and industry, the US and Europe can overcome barriers to care.

Mental Health Patient Advocacy Groups in EU Say Strong Partnerships with Government and Industry Can Ensure Forward Progress

Press Releases | January 25, 2017 | Syneos Health®

New Report from inVentiv Health Examines Mental Health Advocacy Wish Lists and Priorities for Reform

Cool heads in a crisis?

White Papers and Resources | January 25, 2017 | Inizio

Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics

Biosimilars: Bringing patients into the conversation

White Papers and Resources | January 25, 2017 | Inizio

Published in eyeforpharma January 2017 by Mariel Metcalfe

Access and elimination: the future of DAAs in hepatitis C

White Papers and Resources | January 25, 2017 | Inizio

Published in Pharmaphorum January 2017

EphMRA One Day Meeting

White Papers and Resources | January 25, 2017 | Inizio

We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London

Video: Segmentation research

White Papers and Resources | January 25, 2017 | Inizio

Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger...

Pharmaceutical Market Research Conference 2017

White Papers and Resources | January 25, 2017 | Inizio

We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.

Shifting perceptions of the use of probiotics in IBS Management

White Papers and Resources | January 25, 2017 | Inizio

Our client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range...

Nutraceuticals in India: A Challenging Opportunity

White Papers and Resources | January 25, 2017 | Inizio

Published in eyeforpharma December 2016 by Marc Yates